Loading…
3 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Peniksi | (unclassified) | 23.3% | 74th pct | 1208 |
| Developeruli Company Pa… | Real Estate | 27.9% | 57th pct | 246 |
| Janmrteli Tskhovreba | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 2 of 3 peers filed FY2024. Switch to FY2021 (3 of 3).
| Ratio — FY 2024 | Peniksi | Developeruli Company Pa… | Janmrteli Tskhovreba |
|---|---|---|---|
| Margins | |||
| Gross Margin | 34.0% | 46.8% | — |
| EBITDA Margin | 23.3% | 27.9% | — |
| EBITDAR | 706 | 146 | — |
| EBITDAR Margin | 23.3% | 27.9% | — |
| EBIT Margin | 19.8% | 20.9% | — |
| Net Profit Margin | 47.7% | 2.7% | — |
| Operating Expense % of Sales | 10.7% | 18.9% | — |
| Returns | |||
| Return on Assets (ROA) | 13.2% | 0.5% | — |
| Return on Equity (ROE) | 13.7% | 0.5% | — |
| ROIC [EBIT / Invested Capital] | 9.5% | 4.3% | — |
| Leverage & debt balances | |||
| Debt-to-Assets | 0.0% | 1.8% | — |
| Debt-to-Equity | 0.00x | 0.02x | — |
| Debt-to-EBITDA | 0.00x | 0.36x | — |
| Equity-to-Assets | 96.7% | 91.8% | — |
| Net Debt | -4,225 | -184 | — |
| Cash & Equivalents | 4,225 | 237 | — |
| Total Debt | N/A | 53 | — |
| Liquidity & working capital | |||
| Current Ratio | 14.89x | 9.41x | — |
| Quick Ratio | 14.89x | 9.41x | — |
| Cash Ratio | 11.68x | 1.23x | — |
| Total Current Assets | 5,387 | 1,815 | — |
| Total Current Liabilities | 362 | 193 | — |
| Inventory | N/A | N/A | — |
| Trade Receivables | 143 | 352 | — |
| Trade Payables | 362 | 26 | — |
| Net Working Capital | 5,025 | 1,622 | — |
| Net Working Capital % of Revenue | 166.1% | 309.7% | — |
| Trade Working Capital | -219 | 326 | — |
| Trade Working Capital % of Revenue | -7.2% | 62.2% | — |
| Change in Trade Working Capital | N/A | N/A | — |
| Turnover & efficiency | |||
| Inventory Turnover | N/A | N/A | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | — |
| Receivables Turnover | 21.22x | 1.49x | — |
| Days Sales Outstanding (DSO) | 17.2 | 245.6 | — |
| Payables Turnover | 5.52x | 10.52x | — |
| Days Payable Outstanding (DPO) | 66.2 | 34.7 | — |
| Cash Conversion Cycle | -49.0 days | 210.9 days | — |
| Asset Turnover | 0.28x | 0.18x | — |
| Cash flow & dividends | |||
| Operating Cash Flow | 1,652 | N/A | — |
| Free Cash Flow (OCF − Capex proxy) | 1,652 | N/A | — |
| Cash Conversion (OCF / EBITDA) | 234.0% | N/A | — |
| Dividends Declared | N/A | N/A | — |
| Dividend Payout Ratio | N/A | N/A | — |